Everett Harris & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441M | Sell |
|
|||||
|
2025
Q1 | $445M | Sell |
|
|||||
|
2024
Q4 | $555M | Buy |
|
|||||
|
2024
Q3 | $767M | Sell |
|
|||||
|
2024
Q2 | $926M | Sell |
|
|||||
|
2024
Q1 | $834M | Sell |
|
|||||
|
2023
Q4 | $674M | Sell |
|
|||||
|
2023
Q3 | $595M | Sell |
|
|||||
|
2023
Q2 | $533M | Sell |
|
|||||
|
2023
Q1 | $527M | Sell |
|
|||||
|
2022
Q4 | $449M | Buy |
|
|||||
|
2022
Q3 | $330M | Buy |
|
|||||
|
2022
Q2 | $363M | Sell |
|
|||||
|
2022
Q1 | $363M | Buy |
|
|||||
|
2021
Q4 | $366M | Sell |
|
|||||
|
2021
Q3 | $314M | Sell |
|
|||||
|
2021
Q2 | $274M | Buy |
|
|||||
|
2021
Q1 | $220M | Buy |
|
|||||
|
2020
Q4 | $225M | Buy |
|
|||||
|
2020
Q3 | $222M | Buy |
|
|||||
|
2020
Q2 | $209M | Buy |
|
|||||
|
2020
Q1 | $190M | Buy |
|
|||||
|
2019
Q4 | $181M | Sell |
|
|||||
|
2019
Q3 | $161M | Buy |
|
|||||
|
2019
Q2 | $159M | Buy |
|
|||||
|
2019
Q1 | $163M | Buy |
|
|||||
|
2018
Q4 | $143M | Buy |
|
|||||
|
2018
Q3 | $146M | Sell |
|
|||||
|
2018
Q2 | $143M | Buy |
|
|||||
|
2018
Q1 | $153M | Buy |
|
|||||
|
2017
Q4 | $166M | Sell |
|
|||||
|
2017
Q3 | $149M | Sell |
|
|||||
|
2017
Q2 | $134M | Buy |
|
|||||
|
2017
Q1 | $107M | Buy |
|
|||||
|
2016
Q4 | $111M | Buy |
|
|||||
|
2016
Q3 | $126M | Buy |
|
|||||
|
2016
Q2 | $163M | Sell |
|
|||||
|
2016
Q1 | $167M | Sell |
|
|||||
|
2015
Q4 | $179M | Buy |
|
|||||
|
2015
Q3 | $167M | Sell |
|
|||||
|
2015
Q2 | $168M | Sell |
|
|||||
|
2015
Q1 | $167M | Buy |
|
|||||
|
2014
Q4 | $132M | Sell |
|
|||||
|
2014
Q3 | $149M | Sell |
|
|||||
|
2014
Q2 | $146M | Sell |
|
|||||
|
2014
Q1 | $147M | Sell |
|
|||||
|
2013
Q4 | $120M | Buy |
|
|||||
|
2013
Q3 | $109M | Sell |
|
|||||
|
2013
Q2 | $100M | Buy |
|